Question 1

What is Rybelsus and how does it work?

Accepted Answer

Rybelsus (oral semaglutide) is the only GLP-1 receptor agonist available as a tablet rather than an injection. Manufactured by Novo Nordisk, it contains the same active ingredient as Wegovy and Ozempic but is taken daily by mouth. It works by mimicking the GLP-1 hormone to reduce appetite and slow gastric emptying.

Question 2

Is Rybelsus as effective as Mounjaro or Wegovy for weight loss?

Accepted Answer

Clinical trials show Rybelsus produces meaningful weight loss, though generally less than injectable semaglutide (Wegovy) or tirzepatide (Mounjaro) at their maximum doses. However, Rybelsus is the only oral option, making it a good choice for patients who prefer not to inject.

Question 3

How do I take Rybelsus?

Accepted Answer

Rybelsus must be taken on an empty stomach with no more than 120ml of plain water, at least 30 minutes before any food, drink, or other medication. This is important for absorption. Doses start at 3mg daily for 4 weeks, then 7mg, with an option to increase to 14mg.

Question 4

Do I need a prescription for Rybelsus?

Accepted Answer

Yes. Rybelsus is a prescription-only medicine in the UK. A clinical consultation is required before it can be dispensed. Most private online providers include or offer a consultation alongside the prescription.

Question 5

Can I switch from Rybelsus to an injectable GLP-1?

Accepted Answer

Yes. Many patients start with oral Rybelsus and later switch to injectable Wegovy or Mounjaro for greater efficacy. A new clinical assessment is needed. Your prescriber can advise on the best transition approach.

Rybelsus Price Comparison UK

Get price drop alerts

Simple Online Pharmacy

Related treatments